These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 15030455

  • 1. Community-acquired pneumonia: influence of management practices on length of hospital stay.
    Laing R, Coles C, Chambers S, Frampton C, Jennings L, Karalus N, Mills G, Town GI.
    Intern Med J; 2004 Mar; 34(3):91-7. PubMed ID: 15030455
    [Abstract] [Full Text] [Related]

  • 2. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals.
    Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK.
    CMAJ; 2000 May 16; 162(10):1415-20. PubMed ID: 10834044
    [Abstract] [Full Text] [Related]

  • 3. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW, Lindstrom ST.
    Respirology; 2007 Jan 16; 12(1):111-6. PubMed ID: 17207035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB, Rhew DC, Wong JY, Charles RA, Goetz MB, American Thoracic Society.
    Arch Intern Med; 2003 Jul 28; 163(14):1718-26. PubMed ID: 12885688
    [Abstract] [Full Text] [Related]

  • 6. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR, Restrepo MI, Mortensen EM, Burgess DS.
    Am J Med; 2006 Oct 28; 119(10):865-71. PubMed ID: 17000218
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of processes and outcomes of pneumonia care between hospitalists and community-based primary care physicians.
    Rifkin WD, Conner D, Silver A, Eichorn A.
    Mayo Clin Proc; 2002 Oct 28; 77(10):1053-8. PubMed ID: 12374249
    [Abstract] [Full Text] [Related]

  • 9. Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology.
    Laing R, Slater W, Coles C, Chambers S, Frampton C, Jackson R, Jennings L, Karalus N, Mills G, Murdoch D, Town I.
    N Z Med J; 2001 Nov 09; 114(1143):488-92. PubMed ID: 11797872
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.
    Schouten JA, Hulscher ME, Kullberg BJ, Cox A, Gyssens IC, van der Meer JW, Grol RP.
    J Antimicrob Chemother; 2005 Sep 09; 56(3):575-82. PubMed ID: 16049096
    [Abstract] [Full Text] [Related]

  • 12. Declining length of hospital stay for pneumonia and postdischarge outcomes.
    Capelastegui A, España PP, Quintana JM, Gallarreta M, Gorordo I, Esteban C, Urrutia I, Bilbao A.
    Am J Med; 2008 Oct 09; 121(10):845-52. PubMed ID: 18823851
    [Abstract] [Full Text] [Related]

  • 13. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.
    Curr Med Res Opin; 2008 Mar 09; 24(3):895-906. PubMed ID: 18419876
    [Abstract] [Full Text] [Related]

  • 14. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.
    van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Bronsveld W, Jansen HM, Boersma WG.
    Thorax; 2005 Aug 09; 60(8):672-8. PubMed ID: 16061709
    [Abstract] [Full Text] [Related]

  • 15. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.
    Carratalà J, Garcia-Vidal C, Ortega L, Fernández-Sabé N, Clemente M, Albero G, López M, Castellsagué X, Dorca J, Verdaguer R, Martínez-Montauti J, Manresa F, Gudiol F.
    Arch Intern Med; 2012 Jun 25; 172(12):922-8. PubMed ID: 22732747
    [Abstract] [Full Text] [Related]

  • 16. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV, Rhew DC, Murray C, Bratzler DW, Houck PM, Weingarten SR.
    Am J Med; 2006 Jun 25; 119(6):512.e1-7. PubMed ID: 16750965
    [Abstract] [Full Text] [Related]

  • 17. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
    Lee RW, Lindstrom ST.
    Respirology; 2007 Sep 25; 12(5):754-8. PubMed ID: 17875067
    [Abstract] [Full Text] [Related]

  • 18. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.
    Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ.
    Clin Infect Dis; 2008 Feb 15; 46(4):550-6. PubMed ID: 18194099
    [Abstract] [Full Text] [Related]

  • 19. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M, Carratalà J, Ruiz-Gonzalez A, Garcia-Vidal C, Gazquez I, Dorca J, Gudiol F, Porcel JM.
    Respirology; 2009 Jan 15; 14(1):105-11. PubMed ID: 18699803
    [Abstract] [Full Text] [Related]

  • 20. Factors impacting on length of stay and mortality of community-acquired pneumonia.
    Garau J, Baquero F, Pérez-Trallero E, Pérez JL, Martín-Sánchez AM, García-Rey C, Martín-Herrero JE, Dal-Ré R, NACER Group.
    Clin Microbiol Infect; 2008 Apr 15; 14(4):322-9. PubMed ID: 18190569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.